BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 8682287)

  • 1. [Axillary metastases of unknown primary carcinoma].
    Ellend A; Obwegeser R; Auerbach L; Czerwenka K; Kubista E
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):209-13. PubMed ID: 8682287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node axillary metastasis from occult contralateral infiltrating lobular carcinoma arising in accessory breast: MRI diagnosis.
    Capobianco G; Spaliviero B; Dessole S; Rocca PC; Cherchi PL; Ambrosini G; Meloni F; Meloni GB
    Breast J; 2007; 13(3):305-7. PubMed ID: 17461909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary nodal metastasis of occult breast primary cancer.
    Tamiolakis D; Antoniou C
    Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult breast cancer presenting as axillary metastases.
    Yamaguchi H; Ishikawa M; Hatanaka K; Uekusa T; Ishimaru M; Nagawa H
    Breast; 2006 Apr; 15(2):259-62. PubMed ID: 15996865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case.
    Kinoshita S; Hirano A; Kobayashi S; Komine K; Kyoda S; Takeyama H; Uchida K; Morikawa T; Nagase J; Sakamoto G
    Breast Cancer; 2010; 17(1):71-4. PubMed ID: 19259764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult breast carcinoma presenting as an axillary mass.
    Scoggins CR; Vitola JV; Sandler MP; Atkinson JB; Frexes-Steed M
    Am Surg; 1999 Jan; 65(1):1-5. PubMed ID: 9915521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of occult breast carcinoma with irradiation therapy and axillary lymph node dissection].
    Sugiyama Y; Morifuji M; Tatsumoto N; Sasaki M; Naito H; Kai Y
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1287-9. PubMed ID: 16969026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
    Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK
    Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
    Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
    Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma.
    Dragoumis DM; Tsiftsoglou AP; Sikou AD; Assimaki AS
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):517-9. PubMed ID: 18798593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral axillary metastases of occult breast carcinoma: report of a case with a review of the literature.
    Steunebrink M; Schnater JM; Storm RK; van Ingen G; Vegt PA; Plaisier PW
    Breast; 2005 Apr; 14(2):165-8. PubMed ID: 15767189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
    Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
    Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetries in breast cancer lateralization and both axillary lymph node number and metastatic involvement.
    Dane S; Yildirim S; Koc M; Aktan M; Gundogdu C
    Lymphology; 2008 Jun; 41(2):75-9. PubMed ID: 18720914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
    Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.